The long‐term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years

With 10+ years follow‐up in the Leukaemia Research Fund (LRF) CLL4 trial, we report the effect of salvage therapy, and the clinical/biological features of the 10‐year survivors treated for chronic lymphocytic leukaemia (CLL). Overall survival (OS) was similar in the three randomized arms. With fluda...

Descripción completa

Detalles Bibliográficos
Autores principales: Else, Monica, Wade, Rachel, Oscier, David, Catovsky, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Haematological Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832371/
https://www.ncbi.nlm.nih.gov/pubmed/26457986
http://dx.doi.org/10.1111/bjh.13824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832371/
https://www.ncbi.nlm.nih.gov/pubmed/26457986
http://dx.doi.org/10.1111/bjh.13824

Ejemplares similares